Transcription factors regulate gene activity by recognizing specific DNA sequences and influencing whether nearby genes are switched on or off. Their binding sites are embedded in chromatin, the complex of DNA and proteins that packages the genome. Because chromatin structure changes as cells develop or respond to signals, researchers need methods that can map both accessible regions and the physical protection provided by bound proteins. Chromatin-accessibility assays such as MNase-seq, DNase-seq and ATAC-seq infer this organization by fragmenting DNA with enzymes, sequencing the resulting pieces and examining where fragment ends occur. A bound transcription factor can shield a short stretch of DNA from cutting, leaving a footprint in the data. Yet the enzymes themselves may cut some DNA sequences more readily than others. Those sequence preferences can produce apparent footprints at sites where no transcription factor is present, complicating efforts to connect genomic patterns with regulatory activity.

V-plot analysis offers a way to visualize these fragment patterns in two dimensions. For each sequenced DNA fragment, researchers plot its length against the distance between its center and a selected transcription-factor motif. When many fragments are displayed together, their arrangement can form a V-like shape. Fragments that retain information about a protected region tend to occupy the area inside the V, while fragments lacking a remnant of the footprint are represented outside it. The shape is therefore not merely a one-dimensional dip in enzyme cutting; it reflects the relationship between fragment size and position relative to the motif. In routine analyses, researchers may identify a V-shape by eye, but the study argues that visual resemblance alone is insufficient. Sequence bias can generate a V-shaped distribution too, meaning that a motif-associated pattern must satisfy additional geometric and quantitative conditions before it is interpreted as evidence of transcription-factor occupancy.

To investigate the distinction, the researchers examined CTCF, a widely studied transcription factor, using low-dosage micrococcal nuclease sequencing in K562 cells. They compared three classes of genomic locations: highly occupied CTCF motifs positioned near an MNase sequence-bias site, weakly occupied CTCF motifs with a nearby bias sequence, and MNase-bias sequences lacking a nearby CTCF motif. V-shapes appeared in all three categories, confirming that the presence of the pattern itself could not establish binding. Their appearances, however, differed. At occupied CTCF motifs, the V-shape contained a visibly broad channel with few or no signals. This gap is consistent with a region protected from digestion by the bound factor. At MNase-bias sequences, the channel was much narrower, suggesting that the pattern could arise from preferential cleavage rather than a protected protein-DNA interface. Fragment signals were also enriched inside the V at occupied motifs, whereas bias-generated patterns showed a more even distribution between the inside and outside regions.

The authors used several complementary observations to test that interpretation. A CTCF chromatin immunoprecipitation dataset showed strong enrichment within the inside-V area at occupied motifs, an independent indication that the pattern coincided with CTCF binding. The same enrichment was not seen at MNase-bias sequences. Analysis of fragment ends revealed another difference: at occupied motifs, the two flanking digestion hotspots were separated by a broad interval, consistent with a protected footprint between them. That separation was absent at bias sequences. Similar graphical distinctions emerged when the researchers analyzed DNase-seq and ATAC-seq data, despite the different enzymes and experimental principles involved. DNase I and the Tn5 transposase used in ATAC-seq also have sequence preferences, so the recurring contrast suggests that the proposed tests may help identify enzyme-generated patterns across multiple accessibility platforms rather than being limited to MNase-based experiments.

The first criterion is the width of the V-channel, the horizontal region around the motif that is depleted of signals. In principle, this width should approximate the minimum footprint size—the portion of DNA stringently protected under the experimental conditions. The second is inside-V enrichment, which compares fragment density in the interior of the V with density outside it. The researchers used the ratio of these areas to quantify how strongly fragments were concentrated within the footprint-associated region. Their experiments with MAZ, another transcription factor, showed that inside-V enrichment tracked the factor’s occupancy level: motifs with greater enrichment also displayed stronger MAZ chromatin immunoprecipitation signals. The channel width, by contrast, remained relatively constant across groups with different occupancy levels. This separation suggests that enrichment can reflect how much a factor is present, while channel width may reflect an intrinsic aspect of its DNA contact or the way the experiment captures protection.

These measurements are not fixed universal values. The study found that different transcription factors produced different channel widths, potentially because their structures contact DNA through distinct interfaces. Even for the same factor, channel width varied between datasets, indicating that enzyme kinetics and other experimental conditions influence the apparent length of a footprint. Inside-V enrichment was comparatively stable for a given factor across the datasets examined, although the authors emphasize that both parameters are needed for robust classification. They developed a statistical pipeline that uses channel width and inside-V enrichment to separate V-shapes at transcription-factor motifs from those at bias sequences in MNase-seq, DNase-seq and ATAC-seq data. The approach also helped distinguish occupied CTCF motifs from shuffled or unoccupied motifs, with inside-V enrichment alone providing useful separation when long candidate bias sequences were present.

The findings do not eliminate the need for independent validation, and they do not imply that every footprint can be interpreted without considering enzyme bias, motif quality or cellular context. Instead, they provide a practical framework for making V-plot evidence more discriminating, particularly when high-quality chromatin immunoprecipitation data are unavailable. The researchers also reproduced key features of occupied CTCF footprints through in silico MNase digestion, supporting the proposed relationship between protected DNA and the observed geometry. The study’s sequencing data are available through the Genome Sequence Archive under accession HRA017804, and its analysis code is available on GitHub. By requiring a sufficiently broad protected channel together with measurable fragment enrichment inside the V, the authors conclude that researchers can reduce false discoveries while retaining a straightforward way to inspect transcription-factor binding across chromatin-accessibility datasets.

A useful implication of the study is that footprint discovery should be treated as a comparative classification problem rather than as a search for an isolated visual pattern. The relevant question is not simply whether a V-shape occurs near a recognition motif, but whether its geometry and fragment distribution resemble the behavior expected from protected DNA more closely than the behavior of a sequence favored by the assay enzyme. This distinction is especially important at genomic positions where a transcription-factor motif lies close to a cleavage-bias sequence, because the two signals can overlap and make a one-dimensional accessibility profile difficult to interpret.

The proposed measurements also separate two biological or technical features that are often conflated. Inside-V enrichment provides information about the concentration of footprint-bearing fragments and, in the MAZ analysis, changed with the apparent level of occupancy. Channel width instead describes the span of the protected interval under the particular digestion or transposition conditions. Thus, a weak footprint should not automatically be interpreted as a smaller protein-DNA interface, and a broad channel should not automatically be interpreted as stronger binding. The two quantities answer different questions and should be evaluated together when assigning confidence to a candidate site.

This framework offers a way to organize controls within an analysis. Motif-centered plots can be compared with plots centered on bias sequences, shuffled motifs or motifs considered unoccupied, while keeping the sequencing assay and processing strategy consistent. Such comparisons help reveal whether a threshold separates biological signal from an assay-specific background. The study’s examples further suggest that classification cutoffs cannot be assumed to transfer unchanged between transcription factors or between MNase-seq, DNase-seq and ATAC-seq experiments. A robust application therefore requires estimating the relevant distributions in the dataset being analyzed, rather than importing a single footprint size or enrichment value from another experiment.

The in silico digestion results provide a mechanistic bridge between the diagrams and the sequencing observations. When cleavage is restricted across a motif-sized interval, the simulated fragments reproduce the broad vacant channel and the concentration of fragments within the inside-V region seen at occupied sites. This supports the interpretation that the geometry can arise from protection of DNA rather than from an arbitrary plotting artifact. At the same time, the study’s comparison with CTCF chromatin immunoprecipitation illustrates why orthogonal evidence remains valuable: V-plot criteria improve the specificity of inference, but they do not replace information about protein occupancy when such information can be obtained.

For researchers applying the method, the practical output is therefore more informative than a binary label alone. A candidate motif can be accompanied by its channel-width measurement, inside-to-outside fragment ratio and comparison with appropriate bias controls. Reporting these features makes it easier to distinguish sites supported by both criteria from sites driven mainly by one unusual signal. It also creates a clearer basis for comparing occupancy patterns across motifs, cell states or assay types, while preserving the simple visual inspection that makes V-plots attractive for genome-wide chromatin analysis.

Subject of Research: Transcription-factor footprint detection using V-plot analysis

Article Title: Two essential criteria for transcription factor footprint discovery using V-plot

Article References: Two essential criteria for transcription factor footprint discovery using V-plot. (n.d.). https://doi.org/10.1038/s44320-026-00242-5

Image Credits: AI Generated

DOI: 10.1038/s44320-026-00242-5

Keywords: transcription factors, V-plot analysis, chromatin accessibility, MNase-seq, DNase-seq, ATAC-seq, enzyme sequence bias, DNA footprints, essential, criteria, transcription, factor

Traditionally, scientists faced challenges in observing the DNA replication process without damaging the delicate molecular structure of the DNA. Previous methodologies relied on a variety of chemicals that inadvertently compromised the DNA’s integrity. Other strategies resulted in capturing only fragmented sequences, yielding an incomplete picture of the replication dynamics. The challenge was particularly pronounced because understanding the mechanisms underpinning DNA replication is crucial for addressing numerous biological questions and medical conditions.

The researchers developed a novel method, termed RASAM, which stands for “replication-aware single-molecule accessibility mapping.” This technology allows for the comprehensive analysis of DNA at a level of detail previously unattainable. The RASAM technique not only provides long-read sequencing capabilities, which offer a fuller visualization of DNA strands but also incorporates a predictive AI model that helps interpret the data in the context of biological implications. This dual approach sheds light on the molecular events occurring immediately following DNA replication, providing invaluable insights into both normal cellular function and pathological states.

One of the team’s fundamental findings revealed that sections of newly replicated DNA exhibit a state of increased accessibility, described as “hyperaccessible.” This hyperaccessibility persists for several hours post-replication, permitting an unusual level of interaction between the DNA and various proteins, including those implicated in gene regulation. The implications of this discovery are profound, as it challenges long-held assumptions about the stability of nascent DNA post-replication. Instead of being tightly packaged into nucleosome structures, which is typical for mature DNA, the newly formed strands are characterized by a loose configuration, allowing easy access to regulatory proteins.

The observations made by Ramani and his team prompt a reevaluation of the current understanding of genomic stability. It was previously thought that such openness in the DNA structure might lead to chaotic genomic behavior, potentially inducing mutations or misregulation. Surprisingly, their findings indicate that this level of accessibility does not disrupt genomic integrity, suggesting that newly formed DNA has evolved mechanisms to maintain stability while allowing necessary interactions with regulatory proteins. This insight opens new avenues for understanding cellular biology and developing therapeutic strategies for diseases like cancer, where cellular replication is often dysregulated.

The findings hold particularly significant implications for cancer therapies, where understanding the dynamics of DNA replication can lead to innovative treatment approaches. By strategically targeting the hyperaccessible state of nascent DNA, researchers may develop therapies that enhance the efficacy of existing treatments or reduce side effects by capitalizing on the transient nature of this state. This is particularly promising for cancers characterized by rapid cell division, where allowing drugs to interact with cells during this vulnerable phase could enhance therapeutic outcomes.

Embarking on this journey of discovery, Ramani’s research group included key contributors such as Megan Ostrowski and Marty Yang. Together, they showcased the capabilities of the RASAM method through extensive experimentation, revealing not only the accessibility of nascent DNA but also the regulatory mechanisms that govern these interactions. The notion that increased accessibility occurs at specific loci on the DNA, coinciding with the activation of gene expression, emphasizes the intricacies of cellular regulation. Such revelations necessitate further exploration into how nascent DNA is protected and regulated during this critical state.

This realm of inquiry is part of a broader movement called single-cell genomics, which strives to dissect the functional roles of genomes at the individual cell level. The technological advances pioneered by Ramani and his team contribute significantly to this field, offering tools that empower researchers to explore questions that were previously deemed impossible. The ongoing evolution of methodologies in molecular biology aims to provide clearer glimpses into the genomic landscape, ultimately enhancing our understanding of health and disease.

The ability to visualize regions of the genome that were previously obscured by traditional methods underscores the significance of the RASAM approach. With this newfound visibility, scientists can investigate the molecular underpinnings of various diseases and develop strategies to disrupt pathogenic processes effectively. As research progresses, it is anticipated that the knowledge gained from these studies will be instrumental in advancing clinical therapies and diagnostics.

The study’s publication in “Cell” represents not just an academic milestone but a broader narrative about the future of genomic research. By pushing the boundaries of what is observable, this research not only elucidates critical biological processes but also raises new questions that drive scientific progress. As Ramani states, the advancement of methods that facilitate discovery lies at the heart of biological research, emphasizing the need for continuous innovation in the ways scientists explore, analyze, and understand life at the molecular level.

In conclusion, the revelations stemming from this pioneering study on DNA replication are poised to initiate a paradigm shift in both fundamental biology and the approach to therapeutic development. By merging cutting-edge technology with innovative methodologies, the Gladstone Institutes have set a new standard for exploring the intricacies of cellular processes. As the scientific community grapples with the wealth of data now made accessible, the implications of these findings will ripple across the fields of genetics, oncology, and therapeutic research, promoting an era of discovery that could redefine our understanding of life at the most elemental level.

Subject of Research: DNA Replication
Article Title: The single-molecule accessibility landscape of newly replicated mammalian chromatin
News Publication Date: January 21, 2025
Web References: Cell
References: DOI
Image Credits: Gladstone Institutes / Photo by Michael Short

Keywords: DNA Replication, Genetics, Chromatin, Cancer Treatments, Single-Cell Genomics, Genomic Stability, Artificial Intelligence, Molecular Biology, Gene Regulation, Biomedical Research, Gladstone Institutes, RASAM.